Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy

Cancer cells actively release lipid bilayer extracellular vesicles (EVs) that affect their microenvironment, favoring their progression and response to extracellular stress. These EVs contain dynamically regulating molecular cargos (proteins and nucleic acids) selected from their parental cells, rep...

Full description

Bibliographic Details
Main Authors: Yoon-Jin Lee, Shinwon Chae, Dongsic Choi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1256585/full
_version_ 1797672470415671296
author Yoon-Jin Lee
Shinwon Chae
Dongsic Choi
author_facet Yoon-Jin Lee
Shinwon Chae
Dongsic Choi
author_sort Yoon-Jin Lee
collection DOAJ
description Cancer cells actively release lipid bilayer extracellular vesicles (EVs) that affect their microenvironment, favoring their progression and response to extracellular stress. These EVs contain dynamically regulating molecular cargos (proteins and nucleic acids) selected from their parental cells, representing the active biological functionality for cancer progression. These EVs are heterogeneous according to their size and molecular composition and are usually defined based on their biogenetic mechanisms, such as exosomes and ectosomes. Recent single EV detection technologies, such as nano-flow cytometry, have revealed the dynamically regulated molecular diversity within bulk EVs, indicating complex EV heterogeneity beyond classical biogenetic-based EV subtypes. EVs can be changed by internal oncogenic transformation or external stress such as chemotherapy. Among the altered combinations of EV subtypes, only a specific set of EVs represents functional molecular cargo, enabling cancer progression and immune modulation in the tumor microenvironment through their altered targeting efficiency and specificity. This review covers the heterogeneity of EVs discovered by emerging single EV analysis technologies, which reveal the complex distribution of EVs affected by oncogenic transformation and chemotherapy. Encouragingly, these unique molecular signatures in individual EVs indicate the status of their parental cancer cells. Thus, precise molecular profiling of circulating single EVs would open new areas for in-depth monitoring of the cancer microenvironment and shed new light on non-invasive diagnostic approaches using liquid biopsy.
first_indexed 2024-03-11T21:30:32Z
format Article
id doaj.art-17a775754ddb4a8f90b28c5c47d6aba5
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-11T21:30:32Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-17a775754ddb4a8f90b28c5c47d6aba52023-09-27T09:13:04ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-09-011310.3389/fonc.2023.12565851256585Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapyYoon-Jin LeeShinwon ChaeDongsic ChoiCancer cells actively release lipid bilayer extracellular vesicles (EVs) that affect their microenvironment, favoring their progression and response to extracellular stress. These EVs contain dynamically regulating molecular cargos (proteins and nucleic acids) selected from their parental cells, representing the active biological functionality for cancer progression. These EVs are heterogeneous according to their size and molecular composition and are usually defined based on their biogenetic mechanisms, such as exosomes and ectosomes. Recent single EV detection technologies, such as nano-flow cytometry, have revealed the dynamically regulated molecular diversity within bulk EVs, indicating complex EV heterogeneity beyond classical biogenetic-based EV subtypes. EVs can be changed by internal oncogenic transformation or external stress such as chemotherapy. Among the altered combinations of EV subtypes, only a specific set of EVs represents functional molecular cargo, enabling cancer progression and immune modulation in the tumor microenvironment through their altered targeting efficiency and specificity. This review covers the heterogeneity of EVs discovered by emerging single EV analysis technologies, which reveal the complex distribution of EVs affected by oncogenic transformation and chemotherapy. Encouragingly, these unique molecular signatures in individual EVs indicate the status of their parental cancer cells. Thus, precise molecular profiling of circulating single EVs would open new areas for in-depth monitoring of the cancer microenvironment and shed new light on non-invasive diagnostic approaches using liquid biopsy.https://www.frontiersin.org/articles/10.3389/fonc.2023.1256585/fullextracellular vesicleEV subtypeheterogeneitychemotherapysingle EVsliquid biopsy
spellingShingle Yoon-Jin Lee
Shinwon Chae
Dongsic Choi
Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
Frontiers in Oncology
extracellular vesicle
EV subtype
heterogeneity
chemotherapy
single EVs
liquid biopsy
title Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
title_full Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
title_fullStr Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
title_full_unstemmed Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
title_short Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
title_sort monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
topic extracellular vesicle
EV subtype
heterogeneity
chemotherapy
single EVs
liquid biopsy
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1256585/full
work_keys_str_mv AT yoonjinlee monitoringofsingleextracellularvesicleheterogeneityincancerprogressionandtherapy
AT shinwonchae monitoringofsingleextracellularvesicleheterogeneityincancerprogressionandtherapy
AT dongsicchoi monitoringofsingleextracellularvesicleheterogeneityincancerprogressionandtherapy